GATA4 has been shown to interact with SMAD3 25, a member of the TGF-β signaling cascade, and recently also with FOXL2 44, thus linking GATA4 to the fundamental genetic changes in GCT pathogenesis. This evidence concerns the gene TGFB1 and granular cell tumor.